NCT07298512

Brief Summary

To evaluate the presence of TMJ disc perforation on MRI and investigate its associations with internal disc derangements, disc configuration, condylar bone marrow signal patterns, joint effusion, and demographic or clinical variables such as age, sex, dental status, and pain severity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
282

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 3, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 3, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 3, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

December 23, 2025

Completed
Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

1 month

First QC Date

December 3, 2025

Last Update Submit

December 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Presence of TMJ Disc Perforation

    Dichotomous outcome (Yes/No) indicating the presence of temporomandibular joint disc perforation, determined from closed- and open-mouth MRI images assessed by an experienced radiologist/oral and maxillofacial surgeon. Unit of Measure: Percentage of joints with MRI-confirmed disc perforation

    At MRI assessment (baseline, single time point)

Secondary Outcomes (6)

  • Disc Configuration Distribution

    At MRI assessment (baseline)

  • Disc Position (Closed/Open-mouth)

    At MRI assessment (baseline)

  • Condylar Bone Marrow Signal Pattern

    At MRI assessment (baseline)

  • Joint Effusion Grade

    At MRI assessment (baseline)

  • Pain Severity (VAS per TMJ)

    At clinical assessment coincident with MRI (baseline): retrospective clinical data

  • +1 more secondary outcomes

Study Arms (2)

Group 1: Disc Perforation Group

Participants who demonstrate temporomandibular joint (TMJ) disc perforation on MRI. This cohort will be used to evaluate imaging characteristics and clinical parameters associated with perforation.

Group 2: Non-Perforation Group

Participants without MRI evidence of TMJ disc perforation.

Eligibility Criteria

Age14 Years - 79 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population will consist of approximately 282 patients (200 females and 82 males) aged 14-79 years who have undergone TMJ MRI scans for clinical evaluation. Patients will be included if they have complete MRI images (open- and closed-mouth) and corresponding clinical records, including Visual Analogue Scale (VAS) pain scores and detailed dental status. Individuals with systemic disorders affecting bone metabolism, history of bone-altering medications, current orthodontic treatment, prior head or neck trauma or surgery, head or neck cystic or tumoral pathology, previous radiotherapy or chemotherapy, pregnancy, or presence of ferromagnetic objects in the head will be excluded. The population will be stratified into two cohorts based on the presence or absence of TMJ disc perforation as determined by MRI.

You may qualify if:

  • Patients with available temporomandibular joint (TMJ) MRI scans (both open- and closed-mouth)
  • Age ≥14 years
  • Complete clinical records including Visual Analogue Scale (VAS) pain scores and dental status
  • Willingness to participate in the study and provide informed consent (for prospective studies)

You may not qualify if:

  • Presence of systemic disorders affecting bone metabolism, including rheumatoid arthritis, chronic systemic corticosteroid therapy, Paget's disease, hypo- or hyperparathyroidism, osteomalacia, or renal osteodystrophy
  • History of medications that could alter bone architecture
  • Current orthodontic treatment
  • History of head and neck trauma or surgery
  • Presence of head and neck cystic or tumoral pathology
  • Prior radiotherapy or chemotherapy
  • Pregnancy
  • Presence of ferromagnetic objects in the head (contraindication to MRI)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Recep Tayyip Erdoğan University Faculty of Dentistry

Rize, Turkey (Türkiye)

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

December 3, 2025

First Posted

December 23, 2025

Study Start

November 1, 2025

Primary Completion

December 3, 2025

Study Completion

December 3, 2025

Last Updated

December 23, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations